Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.

Autor: Giannoudis A; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Malki MI; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK., Rudraraju B; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London, UK., Mohhamed H; Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Knight Cancer Institute School of Medicine, Portland, USA., Menon S; Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge, UK., Liloglou T; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK., Ali S; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London, UK., Carroll JS; Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge, UK., Palmieri C; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK. c.palmieri@liverpool.ac.uk.; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK. c.palmieri@liverpool.ac.uk.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 16; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2020 Nov 16.

Shear Repair for Reinforced Concrete by Fiberglass Plate Bonding.

Autor: AI-Sulaimani, Ghazi J., Sharif, Alfarabi, Basunbul, lstem A., Baluch, Mohhamed H., Ghaleb, Bader N.

Publikováno v: ACI Structural Journal; Jul/Aug1994, Vol. 91 Issue 4, following p458-464, 12p

The two-faced role of ATF2 on cisplatin response in gastric cancer depends on p53 context.

Autor: Xu, Lingxue¹ (AUTHOR), Wang, Jingjing¹ (AUTHOR), Zhang, Danhua² (AUTHOR), Song, Lijie³ (AUTHOR), Wu, Han^1,2 (AUTHOR), Wang, Jianyao¹ (AUTHOR), Miao, Jinxin¹ (AUTHOR), Guo, Haoran¹ (AUTHOR), Fang, Sujuan¹ (AUTHOR), Si, Lingling¹ (AUTHOR), Chen, Jingfei¹ (AUTHOR), Wu, Yifan¹ (AUTHOR), Wu, Yangyang¹ (AUTHOR), Wang, Lihong¹ (AUTHOR), Zhang, Na¹ (AUTHOR), Chard, Louisa⁴ (AUTHOR), Wang, Yaohe^1,4 (AUTHOR), Cheng, Zhenguo¹ (AUTHOR) chengzhenguo@zzu.edu.cn

Publikováno v: Cell & Bioscience. 5/31/2022, Vol. 12 Issue 1, p1-14. 14p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin–proteasome pathway.

Autor: Feng, Rui, Li, Zhongxing, Ge, Guangcheng, Wang, Chenghao, Jia, Yuejun, Ouyang, Jun

Publikováno v: Clinical & Translational Oncology; Jan2023, Vol. 25 Issue 1, p243-255, 13p